Cargando…

Discovery and Validation of a New Class of Small Molecule Toll-Like Receptor 4 (TLR4) Inhibitors

Many inflammatory diseases may be linked to pathologically elevated signaling via the receptor for lipopolysaccharide (LPS), toll-like receptor 4 (TLR4). There has thus been great interest in the discovery of TLR4 inhibitors as potential anti-inflammatory agents. Recently, the structure of TLR4 boun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Neal, Matthew D., Jia, Hongpeng, Eyer, Benjamin, Good, Misty, Guerriero, Christopher J., Sodhi, Chhinder P., Afrazi, Amin, Prindle, Thomas, Ma, Congrong, Branca, Maria, Ozolek, John, Brodsky, Jeffrey L., Wipf, Peter, Hackam, David J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680486/ https://www.ncbi.nlm.nih.gov/pubmed/23776545 http://dx.doi.org/10.1371/journal.pone.0065779

Ejemplares similares

Breast milk protects against the development of necrotizing enterocolitis through inhibition of Toll Like Receptor 4 in the intestinal epithelium via activation of the epidermal growth factor receptor
por: Good, Misty, et al.
Publicado: (2015)

Innate Immune Signaling in the Pathogenesis of Necrotizing Enterocolitis
por: Hackam, David J., et al.
Publicado: (2013)

Novel Role for the Innate Immune Receptor Toll-Like Receptor 4 (TLR4) in the Regulation of the Wnt Signaling Pathway and Photoreceptor Apoptosis
por: Yi, Hyun, et al.
Publicado: (2012)

Intestinal epithelial Toll-Like Receptor 4 Prevents Metabolic Syndrome by Regulating Interactions Between Microbes and Intestinal Epithelial Cells in Mice
por: Lu, Peng, et al.
Publicado: (2018)

Toll-Like Receptor–Mediated Intestinal Inflammatory Imbalance in the Pathogenesis of Necrotizing Enterocolitis
por: Hackam, David J., et al.
Publicado: (2018)

The human milk oligosaccharides 2’-Fucosyllactose and 6’-Sialyllactose protect against the development of necrotizing enterocolitis by inhibiting Toll-Like Receptor 4 signaling.
por: Sodhi, Chhinder P., et al.
Publicado: (2020)

No Longer an Innocent Bystander: Epithelial Toll-Like Receptor Signaling in the Development of Mucosal Inflammation
por: Gribar, Steven C, et al.
Publicado: (2008)

Maternal aryl hydrocarbon receptor activation protects newborns against necrotizing enterocolitis
por: Lu, Peng, et al.
Publicado: (2021)

TLR4 Inactivation in Myeloid Cells Accelerates Bone Healing of a Calvarial Defect Model in Mice
por: Wang, Dan, et al.
Publicado: (2017)

Enhanced Calvarial Bone Healing in CD11c-TLR4(−/−) and MyD88(−/−) Mice
por: Wang, Dan, et al.
Publicado: (2017)

Mucosa-Associated Bacterial Diversity in Necrotizing Enterocolitis
por: Brower-Sinning, Rachel, et al.
Publicado: (2014)

Precision-based modeling approaches for necrotizing enterocolitis
por: Kovler, Mark L., et al.
Publicado: (2020)

Synthetic Toll Like Receptor-4 (TLR-4) Agonist Peptides as a Novel Class of Adjuvants
por: Shanmugam, Arulkumaran, et al.
Publicado: (2012)

Toll-Like Receptor 4 (TLR4) and Typhoid Fever in Vietnam
por: Hue, Nguyen Thi, et al.
Publicado: (2009)

Phylogenetic variation and polymorphism at the Toll-like receptor 4 locus (TLR4)
por: Smirnova, Irina, et al.
Publicado: (2000)

Toll-Like Receptor 4 (TLR4) and AMPK Relevance in Cardiovascular Disease
por: Vaez, Haleh, et al.
Publicado: (2023)

Toll-like receptor 4 (TLR4): new insight immune and aging
por: Kim, Hyo-Jin, et al.
Publicado: (2023)

A Central Role for Lipocalin-2 in the Adaptation to Short-Bowel Syndrome Through Down-Regulation of IL22 in Mice
por: Zhang, Ailan, et al.
Publicado: (2020)

Toll-Like Receptor (TLR2 and TLR4) Polymorphisms and Chronic Obstructive Pulmonary Disease
por: Budulac, Simona E., et al.
Publicado: (2012)

Expression of Toll-Like Receptors (TLR2 and TLR4) in the Eyes of Mice with Disseminated Acanthamoebiasis
por: Kot, Karolina, et al.
Publicado: (2019)

TLR2 and TLR4 in Parkinson’s disease pathogenesis: the environment takes a toll on the gut
por: Gorecki, Anastazja M., et al.
Publicado: (2021)

Endotoxin-tolerant Mice Have Mutations in Toll-like Receptor 4 (Tlr4)
por: Qureshi, Salman T., et al.
Publicado: (1999)

The Role of Carbohydrates in the Lipopolysaccharide (LPS)/Toll-Like Receptor 4 (TLR4) Signalling
por: Cochet, Florent, et al.
Publicado: (2017)

Toll-like receptor 4 (TLR4) antagonists as potential therapeutics for intestinal inflammation
por: Tam, Janine S. Y., et al.
Publicado: (2021)

Phytochemicals targeting Toll-like receptors 4 (TLR4) in inflammatory bowel disease
por: Dai, Wenbin, et al.
Publicado: (2022)

Tissue engineering for the treatment of short bowel syndrome in children
por: Martin, Laura Y., et al.
Publicado: (2017)

A protein associated with Toll-like receptor (TLR) 4 (PRAT4A) is required for TLR-dependent immune responses
por: Takahashi, Koichiro, et al.
Publicado: (2007)

Toll-Like Receptor (TLR) 2 and TLR4 Differentially Regulate Doxorubicin Induced Cardiomyopathy in Mice
por: Ma, Yonggang, et al.
Publicado: (2012)

Clinical Implication of Toll-Like Receptors (TLR2 and TLR4) in Acute Myeloid Leukemia Patients
por: Aref, Salah, et al.
Publicado: (2020)

Toll-Like Receptor 4 (TLR4) Expression Affects Schwann Cell Behavior in vitro
por: Zhang, Huanhuan, et al.
Publicado: (2018)

FDA Approved Drugs Repurposing of Toll-Like Receptor4 (TLR4) Candidate for Neuropathy
por: Zali, Hakimeh, et al.
Publicado: (2019)

Lung and general health effects of Toll-like receptor-4 (TLR4)-interacting SPA4 peptide
por: Awasthi, Shanjana, et al.
Publicado: (2020)

A Novel Role for Necroptosis in the Pathogenesis of Necrotizing Enterocolitis
por: Werts, Adam D., et al.
Publicado: (2019)

IL-1-driven cartilage and bone destruction are dependent on Toll-like receptor (TLR) 4, but not TLR2
por: Abdollahi-Roodsaz, S, et al.
Publicado: (2005)

Contrasted evolutionary histories of two Toll-like receptors (Tlr4 and Tlr7) in wild rodents (MURINAE)
por: Fornůsková, Alena, et al.
Publicado: (2013)

Correction: Toll-Like Receptor (TLR) 2 and TLR4 Differentially Regulate Doxorubicin Induced Cardiomyopathy in Mice
por: Ma, Yonggang, et al.
Publicado: (2012)

The discriminative capacity of soluble Toll-like receptor (sTLR)2 and sTLR4 in inflammatory diseases
por: ten Oever, Jaap, et al.
Publicado: (2014)

Platelet-Derived Toll-Like Receptor 4 (Tlr-4) Is Sufficient to Promote Microvascular Thrombosis in Endotoxemia
por: Stark, Ryan J., et al.
Publicado: (2012)

Association of Toll-like receptor 4 (TLR4) with chronic plaque type psoriasis and psoriatic arthritis
por: Smith, Rh. Ll., et al.
Publicado: (2016)

Association of Toll-like receptors 4 (TLR-4) gene expression and polymorphisms in patients with severe asthma
por: Shukur, Wasan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_084tb7o5hc51el4s7fpfis4cpm